SCHEMBL13638672

SCHEMBL13638672

C=C1CC(Nc2nccc(-c3ccc(C(C)N)s3)n2)CC(C)(C)N1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK1 P06493 9/20 0.40
CCNB1 P14635 9/20 0.40
CDK4 P11802 9/20 0.40
CDK2 P24941 9/20 0.40
CCND1 P24385 8/20 0.40
CCNA2 P20248 8/20 0.40
CCNA1 P78396 6/20 0.40
CCND3 P30281 4/20 0.40
CDK6 Q00534 4/20 0.40
CCNE1 P24864 1/20 0.40
MAPK10 P53779 4/20 0.32
GSK3B P49841 3/20 0.32
MAPK8 P45983 3/20 0.32
MAPK9 P45984 3/20 0.32
CCNB2 O95067 2/20 0.32
CCNB3 Q8WWL7 2/20 0.32
PIK3C3 Q8NEB9 1/20 0.32
CDC7 O00311 1/20 0.32
PLK4 O00444 1/20 0.32
JAK2 O60674 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4489828 0.86 CDK1 (0.41) CDK1CCNB1CDK4CDK2CCND1
SCHEMBL14612785 0.84 IKBKB (0.37) CDK1CCNB1CDK4CDK2CCND1
SCHEMBL3478664 0.84 CDK1 (0.40) CDK1CCNB1CDK4CDK2CCND1
SCHEMBL13638454 0.84 CDK4 (0.36) CDK1CCNB1CDK4CDK2CCND1
SCHEMBL13638429 0.83 IKBKB (0.34) CDK1CCNB1CDK4CDK2CCND1
SCHEMBL13638420 0.82 KDM4E (0.38) CDK1CCNB1CDK4CDK2CCND1
SCHEMBL13638286 0.82 ROCK2 (0.35) CDK1CCNB1CDK4CDK2CCND1
SCHEMBL13638666 0.82 MAPK10 (0.31) CDK1CCNB1CDK4CDK2CCND1
SCHEMBL13638291 0.82 CDK4 (0.36) CDK1CCNB1CDK4CDK2CCND1
SCHEMBL13638562 0.82 IKBKB (0.39) CDK1CCNB1CDK4CDK2CCND1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7615562-B2 Such as 2-methyl-4-{5-[2-(2,2,6,6-tetramethyl-piperidin-4-ylamino)-pyrimidin-4-yl]-thiophen-2-yl}-butan-2-ol; tumor necrosis factor inhibitors; immunosuppressants; antiinflammatory agents NOVARTIS AG (CH) 2009-11-10 US disclosed